Vivakor Inc. (VIVK): Biotechnology areas of research and acqu...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	785
Posts	128093
Boards Moderated	9
Alias Born	09/26/2011

fast.money

Re: None

Friday, 05/02/2014 1:11:17 PM

Friday, May 02, 2014 1:11:17 PM

Compensated Awareness Post View Disclaimer

Biotechnology areas of research and acquisition are molecular medicine, electro-optics, biological handling and natural and formulary compounds.
$VIVK

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent VIVK News

Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm • PR Newswire (US) • 03/15/2024 04:53:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:24 PM
Socially Responsible Energy Operator Announces Planned Acquisition, Sending Shares Higher • AllPennyStocks.com • 03/04/2024 04:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:10:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 10:17:46 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/09/2024 10:11:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:44:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:00:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:30:19 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/12/2023 10:26:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:45:26 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/24/2023 10:10:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:30:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:41:29 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/17/2023 04:20:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 01:49:21 AM
Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:25:35 PM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 09/06/2023 01:50:55 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2023 01:27:50 AM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 01:56:10 AM

More VIVK News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover